New drug development is a race against the clock as soon as the first patents are filed, and understanding the potential timings from first-in-human studies to regulatory approval is crucial for ...

Options abound for hospitals looking to capitalize on these new data transfer technologies, but so do potential pitfalls. For ...

As clinical development becomes increasingly complex and costly, biotech and pharmaceutical companies are rethinking how they partner with contract research organizations (CROs) to harmonize speed, ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Outsourcing of non-core services and resources is common practice in today’s world as companies look to reduce overhead and costs and streamline their businesses. Pharmaceutical companies outsource ...

In this interview, NewsMedical talks to Amanda Jones at Revvity about the strategies and solutions available to revolutionize the landscape of R&D in clinical research. Can you describe some of the ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

These projects are not only about adding beds or buildings; they represent a broader effort to bring advanced care, clinical ...